Processa Pharmaceuticals (PCSA) Times Interest Earned (2012 - 2025)
Processa Pharmaceuticals' (PCSA) quarterly Times Interest Earned came in at -$205660.5 in Q4 2025, down 21763.83% on a QoQ basis from -$940.64 in Q3 2025.
Processa Pharmaceuticals (PCSA) Times Interest Earned (2012 - 2025) Analysis & Trends
Processa Pharmaceuticals (PCSA) has 14 years of Times Interest Earned data on file, last reported at -$205660.5 in Q4 2025.
- Quarterly Times Interest Earned changed N/A year-over-year to -$205660.5 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$69.55 (changed N/A YoY) and the FY2025 annual result came in at -$0.66, down 8.33% from the prior year.
- Times Interest Earned slipped to -$205660.5 in Q4 2025, from -$940.64 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of -$0.14 in Q4 2023 to a low of -$205660.5 in Q4 2025.
- A 5-year average of -$12595.3 and a median of -$86.48 in 2022 frame the typical range for Times Interest Earned.
- Annual changes were most pronounced in 2021 — Times Interest Earned plunged 112465.55% — and 2023, when it soared 99.18%.
- Tracing PCSA's Times Interest Earned over 5 years: stood at -$28.66 in 2021, then soared by 96.86% to -$0.9 in 2022, then soared by 84.42% to -$0.14 in 2023, then sank by 26095.76% to -$36.67 in 2024, then sank by 560683.69% to -$205660.5 in 2025.
- The last three Times Interest Earned figures came in at -$205660.5 (Q4 2025), -$940.64 (Q3 2025), and -$1007.9 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | Processa Pharmaceuticals | 5.69 Mn | 5.69 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -205,660.50 |
| Sep 30, 2025 | -940.64 |
| Jun 30, 2025 | -1,007.85 |
| Sep 30, 2024 | -36.67 |
| Jun 30, 2024 | -292.41 |
| Mar 31, 2024 | -20.32 |
| Dec 31, 2023 | -0.14 |
| Sep 30, 2023 | -11.62 |
| Jun 30, 2023 | -12.94 |
| Mar 31, 2023 | -17.62 |
| Dec 31, 2022 | -0.90 |
| Sep 30, 2022 | -86.48 |
| Jun 30, 2022 | -1,579.16 |
| Mar 31, 2022 | -794.08 |
| Sep 30, 2021 | -28.66 |
| Jun 30, 2021 | -2,222.09 |
| Mar 31, 2021 | -1,408.68 |
| Dec 31, 2020 | -52.65 |
| Sep 30, 2020 | -15.87 |
| Jun 30, 2020 | -41.04 |